Tech Company Financing Transactions

Circle Pharma Funding Round

Nextech Invest, The Column Group and Eli Lilly and Company participated in a $66 million Series C capital raise for Circle Pharma. The funding round was announced on 6/18/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

681 Gateway Blvd. LGL 3rd Floor
San Francisco, CA 94080
USA

Phone

(650) 825-4099

Website

www.circlepharma.com

Email Address

[email protected]

Overview

We design and develop bioavailable macrocyclic peptide therapeutics against important clinical targets. We do this by applying a computational structure-based design approach that combines physics (conformational modeling), chemistry (innovative molecular components) and biology (protein target structure and function).

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Earp

        

Chief Scientific Officer

Rajinder Singh

        

Co-Founder

Matthew Jacobson

        

Co-Founder

Scott Lokey

        

Vice President

James Aggen

        

VP - Operations

Amy Cowgill

        

VP - R & D

Pablo Garcia

        

VP - R & D

Constantine Kreatsoulas

        

Browse more venture capital transactions:

Prev: 6/18/2021: Angstrom Bio venture capital transaction
Next: 6/18/2021: Ten Little venture capital transaction

Share this article

Where The Data Comes From

We record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary